Consolidated figures · ₹ crore
| ₹ Cr | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1,587 | 1,587 | 2,039 | 2,213 | 774 | 655 | 189 | 66 | 0 | 54 | |
| COGS | 457 | 457 | — | 662 | 188 | 194 | 83 | 24 | 0 | 54 |
| Gross profit | 1,131 | 1,131 | — | 1,551 | 586 | 461 | 106 | 41 | — | -0 |
| 824 | 824 | 1,656 | 1,382 | 659 | 454 | 125 | 55 | 7 | 2 | |
| 306 | 306 | 383 | 169 | -73 | 7 | -19 | -13 | -7 | -2 | |
| OPM % | 19.3% | 19.3% | 18.8% | 7.6% | -9.4% | 1.1% | -10.1% | -20.5% | — | -3.5% |
| Depreciation | 104 | 104 | 154 | 167 | 115 | 80 | 17 | 8 | 0 | 0 |
| Interest | 21 | 21 | 25 | 41 | 37 | 29 | 7 | 5 | 2 | 0 |
| 6 | 6 | 11 | 26 | -211 | -677 | -55 | -92 | 47 | 13 | |
| Profit before tax | 188 | 188 | 216 | -13 | -437 | -779 | -99 | -118 | 37 | 11 |
| Tax | 28 | 28 | 37 | -2 | 14 | 4 | 2 | 1 | 0 | 0 |
| Tax % | 15% | 15% | 17.2% | -15.3% | 3.1% | 0.5% | 1.7% | 1% | 0% | 1.5% |
| 160 | 160 | 178 | -11 | -450 | -782 | -100 | -120 | 37 | 11 | |
| PAT margin % | 10.1% | 10.1% | 8.8% | -0.5% | -58.2% | -119.4% | -53.1% | -182.3% | — | 20% |
| EPS (₹) | 12.2 | 12.2 | 12.1 | -0.9 | -30.9 | -53.5 | -6.9 | -8.2 | 2.6 | 0.7 |
| EPS adjusted (₹) | — | 11 | 12.1 | 4.9 | -30.8 | -53.5 | -6.9 | -8.2 | 2.6 | 0.7 |
| 8.2% | 13.1% | 8.2% | — | — | — | — | — | 0% | — | |
| Annual report | Annual report for Mar 2017 | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 1,314 | 1,504 | 1,561 | 1,110 | 166 | 94 | -23 | 6 | 16 |
| Minority interest | 8 | 9 | 10 | — | — | — | — | — | — |
| 308 | 455 | 514 | 450 | 59 | 33 | 28 | 0 | 0 | |
| 199 | 351 | 384 | 270 | 984 | 83 | 69 | 16 | 5 | |
| Total equity & liabilities | 1,844 | 2,334 | 2,483 | 1,845 | 1,223 | 224 | 88 | 36 | 36 |
| 512 | 785 | 857 | 637 | 84 | 73 | 30 | 0 | 0 | |
| CWIP | 1 | 1 | 1 | 0 | 3 | 10 | — | 0 | — |
| Investments | 59 | 10 | 18 | 8 | — | 0 | 0 | 0 | 0 |
| 1,271 | 1,537 | 1,608 | 1,200 | 1,136 | 141 | 58 | 36 | 36 | |
| Total assets | 1,844 | 2,334 | 2,483 | 1,845 | 1,223 | 224 | 88 | 36 | 36 |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 31 Mar 2022 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Life Sciences | 655.19 | 446.58 | — | 0 |
| Supply Chain Management | 0 | 0 | — | 0 |
₹ crore by fiscal year
| ₹ Cr | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 121 | 104 | 211 | 135 | 30 | 20 | 9 | -16 | -4 | |
| -179 | -485 | -236 | -57 | -31 | -2 | -7 | 22 | 2 | |
| 302 | 100 | 21 | -84 | -55 | -36 | -12 | -3 | -1 | |
| Net cash flow | 244 | -281 | -4 | -6 | -56 | -18 | -10 | 3 | -3 |
| Free cash flow | 38 | -25 | 54 | 132 | -2 | 12 | 1 | -16 | -4 |
| CFO / Operating profit % | 39.4% | 27% | 125% | — | 408% | — | — | — | — |